about
Intra-lesional injection of the novel PKC activator EBC-46 rapidly ablates tumors in mouse modelsCharacterization of the Melanoma miRNAome by Deep SequencingMechanisms contributing to differential regulation of PAX3 downstream target genes in normal human epidermal melanocytes versus melanoma cellsCommon strategies to prevent and modulate experimental cerebral malaria in mouse strains with different susceptibilities.Antiproliferative and phenotype-transforming antitumor agents derived from cysteine.Over-expression of Eph and ephrin genes in advanced ovarian cancer: ephrin gene expression correlates with shortened survival.New cysteine derivatives with antiproliferative activity on melanoma cells.Expression profiling identifies genes involved in neoplastic transformation of serous ovarian cancer.Modification of T cell responses by stem cell mobilization requires direct signaling of the T cell by G-CSF and IL-10Ssb1 and Ssb2 cooperate to regulate mouse hematopoietic stem and progenitor cells by resolving replicative stress.Thrombospondin-4 is a putative tumour-suppressor gene in colorectal cancer that exhibits age-related methylationNFIB Mediates BRN2 Driven Melanoma Cell Migration and Invasion Through Regulation of EZH2 and MITF.Cross-platform array screening identifies COL1A2, THBS1, TNFRSF10D and UCHL1 as genes frequently silenced by methylation in melanoma.Proneural and proneuroendocrine transcription factor expression in cutaneous mechanoreceptor (Merkel) cells and Merkel cell carcinoma.Paclitaxel resistance and multicellular spheroid formation are induced by kallikrein-related peptidase 4 in serous ovarian cancer cells in an ascites mimicking microenvironment.Effect of novel marine nutraceuticals on IL-1α-mediated TNF-α release from UVB-irradiated human melanocyte-derived cells.A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma.Novel mouse model for simulating microsurgical tumor excision with facial nerve preservation.Molecular introduction to head and neck cancer (HNSCC) carcinogenesis.Nuclear targeting of the growth hormone receptor results in dysregulation of cell proliferation and tumorigenesis.IL-1 Contributes to the Anti-Cancer Efficacy of Ingenol Mebutate.Histone deacetylase inhibitors and malignant melanoma.Head and neck cancer: past, present and future.Potent antimalarial activity of histone deacetylase inhibitor analogues.The human genome and gene expression profiling.Reduced alphaB-crystallin staining in perineural invasion of head and neck cutaneous squamous cell carcinoma.Pre-emptive and therapeutic adoptive immunotherapy for nasopharyngeal carcinoma: Phenotype and effector function of T cells impact on clinical response.Therapy for metastatic melanoma: an overview and update.Potential molecular targets for inhibiting bone invasion by oral squamous cell carcinoma: a review of mechanisms.Gene expression profiling in melanoma identifies novel downstream effectors of p14ARF.Furofuran lignans from the Simpson Desert species Eremophila macdonnellii.Validating Eaton's Hypothesis: Cubane as a Benzene Bioisostere.Multimodal polymer nanoparticles with combined 19F magnetic resonance and optical detection for tunable, targeted, multimodal imaging in vivo.REST negatively and ISGF3 positively regulate the human STAT1 gene in melanoma.p53 prevents progression of nevi to melanoma predominantly through cell cycle regulationPestalactams A-C: novel caprolactams from the endophytic fungus Pestalotiopsis sp.Kallikrein-related peptidase 7 promotes multicellular aggregation via the alpha(5)beta(1) integrin pathway and paclitaxel chemoresistance in serous epithelial ovarian carcinoma.The induction of senescence-like growth arrest by protein kinase C-activating diterpene esters in solid tumor cells.H-cadherin expression reduces invasion of malignant melanoma.PPARgamma agonists attenuate proliferation and modulate Wnt/beta-catenin signalling in melanoma cells.
P50
Q21089659-939D3664-7EF4-47D9-93B8-7D152E53E744Q28473165-B30A4DD5-F8A6-4B4B-94F8-A94475FAEB0FQ28546465-CD521D19-2FB4-4217-9CD5-DE5CCC44D897Q30482595-4B400681-9CBE-4366-8D6C-4706845442A4Q31066577-45033EFF-64EA-42DE-AF6B-157FAFC744CAQ33245287-A35E64BB-1B14-4090-AC6B-F8FB7B7AE655Q33247341-63DC4A96-4200-4EE0-BFA7-A8AF713FC2B4Q33511864-C6C298EB-5D25-443A-91BC-5752A598DAC5Q33599208-57956C00-23A4-4F87-922F-C1AF5B6499CBQ33640202-733DA470-9EBB-4C25-9ACD-4E8DDCEB4128Q33693866-9C896318-FB06-416D-B4CF-251641CAD766Q33809465-09CEFBDC-456C-444C-A22F-52A0336C9ABFQ34058385-5C3FBA83-A5CF-4BD3-A6E2-DF5CD5BD81F8Q34147557-E8CC2726-DF1C-4C4E-9F0F-FE1EB7762FB1Q34602948-92F24AFF-A6CE-4C98-88AF-6769ACB5594DQ35231850-ACD6B2AA-43A8-4F05-ACE9-5B285F5FC87DQ35699278-3B13071F-E112-44BF-9AC9-41FE71650B3AQ35740968-40B8EFC0-BB2C-496E-87A6-9DD4834A57EFQ35893787-EF160544-A444-4F9B-9954-47650914AD50Q35941268-856D1422-F7D1-441E-89FF-CC9C5624138AQ35996041-9D524526-6B9B-422E-A45C-4AAD003CAD71Q36126837-DD22175C-9750-4CC4-B0E6-AEAF69269F87Q36532126-9A70A931-CDB0-4430-BA68-72D83D9E9973Q36538672-069E2552-484D-4C20-8940-5B378430D22CQ36571780-B70AB07B-0EB6-4CA8-8D5D-A82EFBCE7A26Q37696728-514B7F96-B1BE-4A9A-836D-1BF70504D24AQ37705026-827E716A-0FA8-4423-8304-6BEE20E55284Q37873464-6C67B2D7-CC73-4E98-BF18-C97C38EF901DQ37958733-FE95BA76-70D4-4539-9CB2-F84324A4ADC6Q38302494-EE6F151B-15F2-44C6-B2FA-69DF46AFE6D6Q38700813-03AFD81B-E951-4667-B574-E29B98978CE9Q38937456-59B3CBDA-D5A7-41C4-A777-BD034272DE85Q39033473-078D4CD0-3CBC-475D-B082-6775F83F9598Q39163958-53EB6597-AA64-4CBE-B597-A260980B3BD1Q39654655-A57C0DEB-6035-4D06-A509-5C87EEB41731Q39706658-372FE5F1-4BDC-4581-8ED5-FCE7DCF9D504Q39723990-D8CF55A2-8904-4820-843D-BC46C99D6CA6Q39820039-9812AF35-B5F5-4E4D-89B8-34D0D9A2C473Q39860814-91705407-2BE8-47ED-A68B-9F611D4A5E47Q39934892-17F04929-CE21-46F2-B97B-26B393912392
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Glen M Boyle
@nl
Glen M Boyle
@sl
Glen M. Boyle
@en
Glen M. Boyle
@es
type
label
Glen M Boyle
@nl
Glen M Boyle
@sl
Glen M. Boyle
@en
Glen M. Boyle
@es
prefLabel
Glen M Boyle
@nl
Glen M Boyle
@sl
Glen M. Boyle
@en
Glen M. Boyle
@es
P1053
G-1347-2013
P106
P21
P31
P3829
P496
0000-0002-1385-529X